BNP, Serum Troponin and D-dimer as Risk Factors in Patients With COVID-19

NCT04433026 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-08-21

No results posted yet for this study

Summary

To evaluate the role of N terminal pro B type natriuretic peptide (NTproBNP), D-Dimer, and Troponin - I as risk factors in COVID-19 patients and to correlate these markers with in-hospital death in patients with COVID-19

Conditions

Interventions

DIAGNOSTIC_TEST

N terminal pro B type natriuretic peptide (NTproBNP), D-Dimer, and serum Tropinin - I

Biomarkers detected in the serum of patients

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-31
Primary Completion
2021-07-01
Completion
2021-09-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04433026 on ClinicalTrials.gov